Phenotypic screening techniques for Cryptosporidium drug discovery.

Abstract excerpt

Introduction: Two landmark epidemiological studies identified Cryptosporidium spp. as a significant cause of diarrheal disease in pediatric populations in resource-limited countries. Notably, nitazoxanide is the only approved drug for treatment of cryptosporidiosis but shows limited efficacy. As a result, many drug discovery efforts have commenced to find improved treatments. The unique biology of Cryptosporidium...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antiprotozoal Agents
• Share to Child
• Share to Cryptosporidiosis